Shahrokh Javaheri | Medicine and Health Sciences | Best Researcher Award

Posted on by Research Hypothesis

Prof. Shahrokh Javaheri | Medicine and Health Sciences | Best Researcher Award

Sleep Physicia at Bethesda North Hospital, United States

Dr. Shahrokh Javaheri is a highly respected Professor Emeritus at the University of Cincinnati College of Medicine and a leading figure in pulmonary and sleep medicine. With medical training from Pahlavi University and advanced research fellowships at prestigious institutions such as Harvard Medical School and the University of Pennsylvania, he has built an illustrious career spanning over 40 years. He has held numerous influential roles, including Director of Pulmonary Function and Sleep Disorders Laboratories at the Veterans Affairs Medical Center in Cincinnati, and served as a consultant and clinical leader at multiple institutions. Board-certified in Internal Medicine, Pulmonary Medicine, Critical Care, and Sleep Medicine, Dr. Javaheri has contributed significantly to clinical research, academic mentorship, and patient care. His active affiliations with leading societies like the American Thoracic Society and the European Respiratory Society highlight his ongoing influence in the global medical community. Through his enduring dedication to science and medicine, Dr. Javaheri continues to shape the field with his expertise and clinical insight.

Professional Profile 

🎓 Education Summary: Dr. Shahrokh Javaheri

Dr. Shahrokh Javaheri received his foundational medical education at Pahlavi University Medical School (now Shiraz University of Medical Sciences) in Shiraz, Iran, where he earned his M.D. in 1970. He began his postgraduate training with clinical exposure in the Pulmonary Unit at Massachusetts General Hospital in Boston during 1969–1970, laying the groundwork for his future specialization. Following his internship and national service as a medical officer in Iran, he pursued an internal medicine residency at Pahlavi Medical School. To further specialize, he completed a renal fellowship at the University of Pennsylvania and then underwent rigorous clinical and research fellowships in Pulmonary Medicine at Massachusetts General Hospital, affiliated with Harvard Medical School, from 1975 to 1978. His education and training reflect a blend of international excellence and intensive specialization, forming a strong foundation for his subsequent contributions to pulmonary and sleep medicine.

💼 Professional Experience Summary: Dr. Shahrokh Javaheri

Dr. Shahrokh Javaheri has had a distinguished and extensive professional career spanning over four decades in academic medicine, clinical practice, and research. He began his academic journey as an Assistant Professor of Medicine at Boston University School of Medicine (1978–1980), concurrently serving as Director of the Pulmonary Function Laboratories at Boston City Hospital. He later contributed internationally as an Associate Researcher at Ghent University in Belgium before relocating to Cincinnati, where he became a central figure in pulmonary and sleep medicine. From 1983 to 2003, he held key positions at the Veterans Affairs Medical Center, including Director of the Pulmonary Function and Sleep Disorders Laboratories and Assistant Chief of the Pulmonary Section. Simultaneously, he served at the University of Cincinnati College of Medicine, rising from Associate Professor to Professor of Medicine, specializing in Pulmonary Disease and Critical Care. Following his transition to Professor Emeritus in 2003, he remained actively engaged in clinical practice as a Sleep Physician at Bethesda North Hospital and a consultant with the Will Rogers Institute. His career reflects a rare combination of clinical leadership, academic excellence, and dedication to advancing patient care in pulmonary and sleep medicine.

🔬 Research Interests Summary: Dr. Shahrokh Javaheri

Dr. Shahrokh Javaheri’s research interests are centered on sleep-disordered breathing, heart failure-related sleep apnea, pulmonary physiology, and the intersection of sleep medicine with cardiovascular disease. A pioneer in the clinical study of central and obstructive sleep apnea, he has contributed significantly to understanding how sleep-related breathing disorders impact cardiac function and overall health outcomes. His work has explored the mechanisms and treatment responses in patients with Cheyne-Stokes respiration, chronic heart failure, and sleep-related hypoventilation, making him a leading authority in this nuanced and evolving field. Dr. Javaheri’s research also emphasizes the use of non-invasive ventilation therapies, such as CPAP and adaptive servo-ventilation, and their clinical outcomes. His multidisciplinary approach bridges pulmonology, sleep medicine, and cardiology, reflecting a deep commitment to translating physiological insights into effective clinical interventions for complex, high-risk patient populations.

🏅 Awards and Honors Summary: Dr. Shahrokh Javaheri

Dr. Shahrokh Javaheri has been recognized with numerous honors and distinctions throughout his extensive career, reflecting his outstanding contributions to pulmonary and sleep medicine. He holds the prestigious title of Professor Emeritus at the University of Cincinnati College of Medicine, a recognition reserved for faculty with exceptional academic and clinical service. His board certifications in Internal Medicine, Pulmonary Medicine, Critical Care, and Sleep Medicine underscore his elite professional standing. In addition, he is a Fellow of the American Academy of Sleep Medicine, a mark of distinction for leaders in the field. Dr. Javaheri’s enduring affiliations with premier medical societies, including the American Thoracic Society, American College of Chest Physicians, and European Respiratory Society, further highlight his respected status in the global medical community. His roles as a clinical consultant, academic mentor, and sleep medicine expert have earned him lasting recognition and respect across institutions and disciplines.

✅ Conclusion:

Dr. Shahrokh Javaheri is highly suitable for the Best Researcher Award, particularly in the domains of Sleep Medicine, Pulmonary Disease, and Internal Medicine. His prolific and sustained career, board-certified expertise, academic appointments, and clinical leadership establish him as a well-rounded and impactful physician-researcher. With minor enhancement in showcasing recent research metrics or translational innovations, his profile would stand as exemplary on both national and international fronts.

📝 Selected Publications by Dr. Shahrokh Javaheri

  1. Title: Interactions of Obstructive Sleep Apnea With the Pathophysiology of Cardiovascular Disease, Part 1: JACC State-of-the-Art Review
    Authors: Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T, Javaheri S
    Year: 2020
    Citations: 19

  2. Title: Treatment of OSA and its Impact on Cardiovascular Disease, Part 2: JACC State-of-the-Art Review
    Authors: Somers VK, Javaheri S, et al.
    Year: 2020
    Citations: 10

  3. Title: Medication-induced central sleep apnea: a unifying concept
    Authors: Javaheri S, Dempsey JA
    Year: 2022
    Citations: 7

  4. Title: Distinguishing central from obstructive hypopneas on a clinical polysomnogram
    Authors: Javaheri S, Malhotra A
    Year: 2021
    Citations: 19

  5. Title: Cardiovascular Risks in People With Narcolepsy: Expert Panel Consensus Recommendations
    Authors: Javaheri S, Black J, Foldvary-Schaefer N, Malhotra RK, Zee PC, et al.
    Journal: Journal of the American Heart Association
    Year: 2024
    Citations: 1

  6. Title: A call for precision medicine: Facing the challenge of sleep-disordered breathing in heart failure
    Authors: Javaheri S, et al.
    Type: Editorial
    Year: 2023
    Citations: 1

  7. Title: Sleep, Hypoxia, and Survival in Group 1 Pulmonary Arterial Hypertension: What to Do?
    Authors: Javaheri S
    Type: Editorial
    Year: 2023
    Citations: 0

  8. Title: Guest editorial: Phrenic nerve stimulation for treatment of central sleep apnea
    Author: Javaheri S
    Year: 2022
    Citations: 0

 

Yashwant Pathak | Medicine and Health Sciences | Best Researcher Award

Posted on by Research Hypothesis

Prof. Yashwant Pathak | Medicine and Health Sciences | Best Researcher Award

Professor at Univ of South Florida Taneja College of Pharmacy, United States

Professor Yashwant V. Pathak is a globally renowned pharmaceutical scientist, educator, and research leader with a distinguished academic and international career spanning over four decades. Currently serving as Associate Dean and Full Professor at the University of South Florida’s Taneja College of Pharmacy, he has made groundbreaking contributions in nanotechnology, drug delivery systems, nutraceuticals, and healthcare education. A recipient of prestigious honors such as the Fellowship of the American Association for the Advancement of Science (AAAS) and multiple Fulbright Fellowships, Dr. Pathak has conducted postdoctoral research at elite institutions and lectured in over 100 universities across 80+ countries. His scholarly output exceeds 5,200 citations with an h-index of 33, and he has authored and edited numerous influential books, including the award-winning Handbook of Space Pharmaceuticals. With significant roles in research leadership, global collaborations, and interdisciplinary education, Professor Pathak exemplifies the highest standards of innovation, academic excellence, and global impact in science.

Professional Profile 

🎓 Educational Journey of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak’s educational background reflects a dynamic fusion of science, management, and interdisciplinary expertise. He began his academic journey with a Bachelor of Pharmacy (B.Pharm, 1975) and a Master of Pharmacy (M.Pharm, 1977) in Pharmaceutical Technology from Nagpur University, India, laying a strong foundation in pharmaceutical sciences. He further advanced his specialization by earning a Ph.D. in Pharmaceutical Sciences (1989) from the same institution. Demonstrating a commitment to leadership and holistic development, he pursued an Executive MBA in Business Management (2009) and a Master of Science in Conflict Management (MSCM, 2010) from Sullivan University, USA, graduating Summa Cum Laude in both programs. This diverse educational portfolio has empowered Dr. Pathak with a rare blend of technical expertise, strategic thinking, and conflict resolution—making him a uniquely qualified academic leader and international research collaborator.

💼 Professional Experience of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak brings over four decades of rich and diverse professional experience across academia, industry, and global research institutions. Currently serving as Associate Dean for Faculty Affairs and Full Professor at the University of South Florida (USF), he has held key leadership roles including Chair of International Working Groups and Director of Nanotechnology Centers. His previous appointments include Assistant Dean for Research and Graduate Programs at Sullivan University, USA, and Director of R&D at Neos Therapeutics, Texas, reflecting his strong industry-academia interface. He has also served as a pharmaceutical consultant for international tech transfer and worked as a postdoctoral fellow and visiting scientist at esteemed global institutions including the University of Michigan (USA), Hebrew University (Israel), and Royal Free Hospital (UK). His expertise spans pharmaceutical R&D, academic administration, and interdisciplinary collaborations, and he has made significant contributions to institutional growth, research innovation, and global education.

🔬 Research Interests of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak’s research interests are at the forefront of interdisciplinary science, spanning nanotechnology-based drug delivery systems, pharmaceutical innovations, nutraceuticals, and space pharmaceuticals. His pioneering work in nanomedicine and siRNA delivery technologies has positioned him as a global authority in targeted and controlled drug delivery mechanisms. He is deeply engaged in exploring the impact of microgravity on drug formulations, contributing significantly to the emerging field of space pharmacology. Additionally, Dr. Pathak’s interest in artificial intelligence in healthcare, conflict management in scientific collaborations, and the development of functional foods and nutraceuticals demonstrates his commitment to integrating science with global health and policy challenges. His multidisciplinary approach not only advances pharmaceutical sciences but also addresses broader health and sustainability issues on an international scale.

🏆 Awards and Honors of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak has been the recipient of numerous prestigious national and international awards that reflect his outstanding contributions to science, education, and global collaboration. Most notably, he is a Fellow of the American Association for the Advancement of Science (AAAS), one of the highest honors in the scientific community. He has received four Fulbright Fellowships across countries such as Indonesia, South Africa, Colombia, and the Czech Republic—recognizing his expertise in nanotechnology and pharmaceutical sciences. His book Handbook of Space Pharmaceuticals received the Book of the Year Award (2022) from the International Academy of Aeronautics. He has also been honored with fellowships and grants from government agencies in Australia, Brazil, Ecuador, China, Nigeria, and the USA, including the Endeavour Executive Fellowship, CNPQ Fellowship, and Mandela Washington Fellowship. At the University of South Florida, he has been repeatedly recognized with Outstanding Faculty Awards, a Global Engagement Achievement Award, and the USF Outstanding Research Faculty Award, underscoring his leadership in academia and research.

🏁 Conclusion

His global impact, interdisciplinary leadership, prolific scholarly output, and academic excellence firmly position him as a trailblazer in pharmaceutical sciences and allied fields. His contributions reflect not only intellectual brilliance but also a deep commitment to global scientific collaboration and education.

📚 Publications of Jibamitra Ganguly

          1. Title: CAR T cells in solid tumors: challenges and opportunities
              Authors: F. Marofi, R. Motavalli, V.A. Safonov, L. Thangavelu, A.V. Yumashev, …
              Year: 2021
              Citations: 611

          2. Title: Nanoparticulate drug-delivery systems: an overview
              Authors: D. Thassu, Y. Pathak, M. Deleers
              Year: 2007
              Citations: 349

          3. Title: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders
              Authors: A. Markov, L. Thangavelu, S. Aravindhan, A.O. Zekiy, M. Jarahian, …
              Year: 2021
              Citations: 310

         4. Title: A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine
             Authors: S. Moghadasi, M. Elveny, H.S. Rahman, W. Suksatan, A.T. Jalil, …
             Year: 2021
             Citations: 279

         5. Title: Drug delivery nanoparticles formulation and characterization
             Authors: Y. Pathak, D. Thassu
             Year: 2009
             Citations: 224

          6. Title: Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients
              Authors: F. Marofi, H.S. Rahman, Z.M.J. Al-Obaidi, A.T. Jalil, W.K. Abdelbasset, …
             Year: 2021
             Citations: 195

         7. Title: Polyacrylate (Eudragit retard) microspheres for oral controlled release of nifedipine. I. Formulation design and process optimization
             Authors: A. Barkai, Y.V. Pathak, S. Benita
             Year: 1990
             Citations: 169

         8. Title: Ocular drug delivery: impact of in vitro cell culture models
             Authors: A. Solanki, S. Desai, A. Grover, A. Hirani, Y. Pathak, V. Sutariya
             Year: 2016
             Citations: 165

         9. Title: Surface modification of nanoparticles for targeted drug delivery
             Authors: P. Patel, A. Hanini, A. Shah, D. Patel, S. Patel, P. Bhatt, Y.V. Pathak
             Year: 2019
             Citations: 139

       10. Title: Targeting nanoparticles as drug delivery systems for cancer treatment
             Authors: K. Subramani, H. Hosseinkhani, A. Khraisat, M. Hosseinkhani, Y. Pathak
             Year: 2009
             Citations: 112

 

 

Albina Tummolo | Medicine and Health Sciences | Best Researcher Award

Posted on by Research Hypothesis

Dr. Albina Tummolo | Medicine and Health Sciences | Best Researcher Award

Albina Tummolo at Children Hospital Giovanni XXIII, Italy.

Dr. Albina Tummolo is an accomplished pediatrician specializing in metabolic and genetic disorders. With over two decades of clinical and academic experience, she has built a significant profile in managing and researching rare pediatric diseases. Based at the Policlinico of Bari, she combines patient care with academic research, national coordination roles, and continuous engagement with international advisory boards. Dr. Tummolo is also an active educator, teaching at several Italian universities and training healthcare professionals in hereditary metabolic diseases. Her work has shaped protocols and policies for improved pediatric metabolic care in Italy.

Publication Profile

Orcid

Education

Dr. Albina Tummolo earned her Degree in Medicine and Surgery from the University of Foggia in 2002 and completed her Specialization in Pediatrics (General and Specialist) at the University of Bari in 2007. She holds multiple postgraduate certifications in specialized pediatrics, infectivity, rheumatology, and rare diseases from the University of Bari and the University of Florence. She furthered her academic credentials with an MSc in Clinical Pediatrics from University College London in 2008 and a PhD in Pediatric Sciences from the University of Bari in 2011. In 2023, she completed an MSc in Epidemiology and Biostatistics at Università Cattolica di Roma.

Experience

Dr. Tummolo currently serves as a Senior Pediatrician at the Ospedale Pediatrico “Giovanni XXIII” in Bari, within the Unit of Metabolic and Genetic Diseases, a role she has held since 2015. She has also worked as a senior pediatrician at the Azienda Ospedaliera di Padova and Presidio Ospedaliero “Perrino” dell’ASL di Brindisi. She is a registered physician with the Order of Physicians and Surgeons of Bari (License No. 5742, since September 18, 2003).

Dr. Tummolo has extensive experience leading and participating in clinical trials and observational studies focused on inborn errors of metabolism, lysosomal storage disorders, and rare genetic conditions, often acting as Principal Investigator or Scientific Coordinator. She serves as a member and secretary of national expert committees and advisory boards and contributes to shaping diagnostic and therapeutic strategies for metabolic disorders in Italy and Europe.

Research Focus

  • Inborn errors of metabolism and rare genetic diseases

  • Lysosomal storage disorders (including LAL-D, Gaucher disease, and alpha-mannosidosis)

  • Phenylketonuria (PKU) and organic acidurias

  • Neonatal screening programs

  • Epidemiology and real-world evidence in pediatric metabolic disorders

  • Nutritional and enzyme replacement therapies in pediatric populations

Author Metrics & Scientific Contributions

  • Principal Investigator in multiple national and international clinical trials

  • Scientific Member of the Telethon Undiagnosed Diseases Program (TUDP) and E-HOD

  • Coordinator/Advisor for over 30 expert boards and working groups, including SIMMESN

  • Co-author of educational and clinical monographs, including:

    • “Inherited Metabolic Disorders Neonatal Screening” (2014)

    • Educational booklets on MSUD, TYR, HCU, MMA/PA, GA, IVA, and PKU (2020–2022)

    • Springer Healthcare Monography (2025) on velmanase alfa treatment in alpha-mannosidosis

She has contributed substantially to national consensus statements, educational masterclasses, and international forums on metabolic disease management.

Publication Top Notes

1. Exploring Partners, Parenting and Pregnancy Thinking in Late Adolescents and Young Adults with Inherited Metabolic Disorders

📅 Pediatric Reports, May 2025
🔗 DOI: 10.3390/pediatric17030056
👩‍🔬 Contributors: Albina Tummolo, Giulia Paterno, Rosa Carella, Livio Melpignano, Donatella De Giovanni
Focus: Examines reproductive health perspectives in adolescents and young adults affected by inherited metabolic disorders.

2. Growth Parameters and Prevalence of Obesity in PKU Patients and Peers: Is This the Right Comparison?

📅 Pediatric Reports, October 2024
🔗 DOI: 10.3390/pediatric16040076
👩‍🔬 Contributors: Giulia Paterno, Vito Di Tullio, Rosa Carella, Giada De Ruvo, Fabrizio Furioso, Aleksandra Skublewska-D’Elia, Donatella De Giovanni, Albina Tummolo
Focus: Investigates obesity prevalence among patients with phenylketonuria (PKU) versus healthy peers.

3. Intake Modalities of Amino Acid Supplements: A Real-World Data Collection from Phenylketonuria Patients

📅 Nutrients, February 2024
🔗 DOI: 10.3390/nu16050669
👩‍🔬 Contributors: Albina Tummolo, Rossella Carella, Pasquale Carone, Giulia Paterno, Donatella De Giovanni
Focus: Real-world insights into how PKU patients consume amino acid supplements.

4. CHAMP1-related Disorders: Pathomechanisms Triggered by Different Genomic Alterations Define Distinct Nosological Categories

📅 European Journal of Human Genetics, 2023
🔗 DOI: 10.1038/S41431-023-01305-Z
🔍 WOSUID: WOS:000939855800002
👩‍🔬 Contributors: Amenta S., Marangi G., Orteschi D., Frangella S., Gurrieri F., Paccagnella E., Scala M., Romano F., Capra V., Nigro V., et al.
Focus: Differentiates clinical categories of CHAMP1-related disorders based on genomic mechanisms.

5. Long-term Safety and Efficacy of Velmanase Alfa Treatment in Children Under 6 Years of Age with Alpha-Mannosidosis: A Phase 2, Open Label, Multicenter Study

📅 Journal of Inherited Metabolic Disease, 2023
🔗 DOI: 10.1002/JIMD.12602
🔍 WOSUID: WOS:000948401000001
👩‍🔬 Contributors: Guffon N., Konstantopoulou V., Hennermann J.B., Muschol N., Bruno I., Tummolo A., Ceravolo F., Zardi G., Ballabeni A., Lund A.
Focus: Evaluates velmanase alfa’s therapeutic profile in pediatric alpha-mannosidosis patients.

Conclusion

Dr. Albina Tummolo exemplifies the core values of the Best Researcher Award in Medicine and Health Sciences through her compassion-driven pediatric care, trailblazing research, and influence on national health systems. Her unique blend of clinical depth, academic rigor, and policy impact makes her an ideal candidate for this recognition.

She not only advances medical science but also improves the lives of children with rare diseases—one diagnosis, one protocol, and one family at a time.

Jim Sheu | Medicine and Health Sciences | Hypothesis Achievement Award

Posted on by Research Hypothesis

Jim Sheu | Medicine and Health Sciences | Hypothesis Achievement Award

Prof Jim Sheu, National Sun Yatsen University, Taiwan

Prof. Jim Sheu is a distinguished biomedical scientist with over two decades of academic and research excellence in life sciences. Holding a Ph.D. in Life Science from National Tsing-Hua University (2002), he has consistently advanced the frontiers of molecular oncology, stem cell therapy, and women’s reproductive health. Currently a professor at National Sun Yat-sen University, Taiwan, he has previously held prestigious research and academic positions at China Medical University and Johns Hopkins Medical Institutions. He is widely recognized for his role in leading innovative biomedical projects and mentoring the next generation of scientists. Prof. Sheu has made pioneering contributions to cancer genomics, glioblastoma therapeutics, and endometriosis research. His prolific publication record and multiple awards underline his leadership and innovation in the field. His work bridges translational research with clinical applications, shaping modern therapeutic strategies.

Publication Profile

Google Scholar

Education

Prof. Jim Sheu’s educational journey laid a strong foundation for his impactful scientific career. He earned his Ph.D. in Life Science from the prestigious National Tsing-Hua University, Taiwan, in 2002 🧬. This doctoral training provided him with deep expertise in molecular biology, genetics, and biomedical research. Prior to that, he completed his B.S. in Biology from Fu-Jen University, Taiwan, in 1994 🧪. The rigorous academic environment at these institutions honed his critical thinking and experimental skills. His thesis and postdoctoral work involved advanced molecular techniques and translational research applications. With education deeply rooted in cellular biology and medical biotechnology, Prof. Sheu has seamlessly integrated his academic background with real-world research, evolving into a leading expert in cancer biology, stem cell therapies, and women’s health. His academic excellence has continued to inspire his students and collaborators across various institutes.

Experience

Prof. Sheu’s career spans academia, clinical research, and biotechnology. Since 2014, he has served as Professor at the Institute of Biomedical Sciences, National Sun Yat-sen University 🏫. Previously, he held multiple roles at China Medical University (2006–2014), including Researcher, Professor, Associate Professor, and Assistant Professor in the Graduate Institute of Chinese Medical Science 🧑‍🏫. His early international experience includes being a Research Fellow at Johns Hopkins Medical Institutions (2004–2006) 🔬. He also held leadership positions at Taiwan’s Development Center for Biotechnology (2003–2004), directing and managing key protein drug and biomedicine projects. His academic and research trajectory is marked by interdisciplinary innovation, integrating biomedical engineering, genetics, and pharmacology. Prof. Sheu’s deep involvement in translational research and collaborative initiatives underpins his reputation as a scientific leader in Taiwan and beyond.

Awards & Honors

Prof. Sheu has earned several prestigious honors celebrating his research excellence and innovation. In 2023, he was part of the award-winning Biomedical Team at National Sun Yat-sen University for a serum-free stem cell medium at the NBRP Pitch Day 🧫🏅. He also received the Outstanding Faculty of Basic Research award and the Tien-Te Lee Award for an outstanding poster on stem cell therapies for Parkinson’s disease. In 2022, he was honored by the Taiwan Endometriosis Society for his research using traditional medicine to modulate immune responses 🌿🧠. Additionally, he won the Prof. Chii-Ruey Tzeng Award for an impactful paper in endometriosis research. These accolades highlight Prof. Sheu’s interdisciplinary impact, bridging traditional Chinese medicine, molecular biology, and cutting-edge therapeutic development. His continuous recognition by scientific communities underscores his leadership in biomedical innovation.

Research Projects

Prof. Jim Sheu has actively contributed as a project reviewer in the field of life sciences since 2012 🌱. He serves the National Science and Technology Council (NSTC) in Taiwan and has reviewed projects for various institutions including Tri-Service General Hospital (2021–present), Kaohsiung Veterans General Hospital (2021–present), and Zuoying Armed Forces General Hospital (2020–present) 🏥. He also evaluated projects for National Tsing-Hua University (2023) and Kaohsiung Chang Gung Smart Hospital (2022) 🎓. His expertise has extended globally, reviewing for Italy’s Ministry of Health in 2015 🇮🇹 and South Africa’s Medical Research Council in 2012 🇿🇦, showcasing his international recognition 🌍.

Research Focus

Prof. Sheu’s research is centered on cancer biology, stem cell therapy, gynecological diseases, and translational medicine. He explores the molecular mechanisms of tumor progression, particularly in microsatellite instability and glioblastoma 🔍🧠. His investigations into ethnic-specific genetic markers for endometriosis and ovarian aging highlight his commitment to personalized medicine. Another focus lies in the regulation of immune responses using traditional herbal compounds, bridging modern molecular science with Eastern medicine 🌿🧪. He has led multi-omics studies that decode complex disease pathways, including mitochondrial dysfunction in breast cancer. Additionally, he is advancing serum-free stem cell enhancement technologies aimed at clinical application. Prof. Sheu’s interdisciplinary approach links genomics, proteomics, and pharmacology, translating basic research into viable therapeutic strategies. His work significantly contributes to understanding cellular aging, reproductive biology, and cancer therapy.

Publication Top Notes

Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma

Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma

A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival

Puerariae radix isoflavones and their metabolites inhibit growth and induce apoptosis in breast cancer cells

Autophagy and its link to type II diabetes mellitus

Talin‐1 overexpression defines high risk for aggressive oral squamous cell carcinoma and promotes cancer metastasis

Kaempferol inhibits enterovirus 71 replication and internal ribosome entry site (IRES) activity through FUBP and HNRP proteins

 

 

 

Yuanli Zhang | Medicine and Health Sciences | Best Researcher Award

Posted on by Research Hypothesis

Yuanli Zhang | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr Yuanli Zhang, Chongqing Three Gorges Medical College, China

Assoc. Prof. Dr. Yuanli Zhang is a distinguished academic and the Deputy Secretary of the School of Medical Technology at Chongqing Three Gorges Medical College 🇨🇳. With over a decade of dedication to the field of oral biomechanics 🦷🧠, he has significantly advanced knowledge in orthodontics, implantation, and jaw surgery. Dr. Zhang has published more than 20 peer-reviewed papers 📚 and is a lead contributor to several innovative research projects focused on temporomandibular joint (TMJ) dysfunction, integrating engineering and medicine 🤖🧪. He also holds multiple national patents 🧾, reflecting his innovative work in dental biomechanics and medical imaging. His scholarly books, including one published by CRC Press, are used widely in the field. Dr. Zhang’s commitment to research excellence, innovation, and education marks him as a leading figure in biomedical engineering and dental science 🏅.

Publication Profile

Orcid

Education

Dr. Yuanli Zhang holds a rigorous academic background in biomechanics and medical engineering ⚙️🩺. He completed his undergraduate and postgraduate studies in biomedical-related disciplines, focusing on musculoskeletal system analysis and oral-maxillofacial biomechanics. His expertise has been deepened through advanced studies in computational modeling and finite element analysis 💻📐. Dr. Zhang’s education combines theoretical knowledge with hands-on research experience, especially in the simulation and mechanical evaluation of the temporomandibular joint (TMJ). He has also received extensive training in the application of ABAQUS finite element software, which he later translated into a best-selling textbook. His academic formation laid a strong foundation for multidisciplinary collaboration across medicine, dentistry, and mechanical engineering 🤝. This comprehensive educational pathway has empowered him to design and execute complex research projects and contribute meaningfully to both clinical and academic communities 🏫📖.

Experience

Assoc. Prof. Dr. Yuanli Zhang currently serves as the Deputy Secretary of the School of Medical Technology at Chongqing Three Gorges Medical College 🏫. With over ten years of research and academic leadership experience, he specializes in oral biomechanics, integrating clinical insights with mechanical engineering principles 🦷⚙️. He has directed numerous research projects on TMJ dysfunction, prosthodontics, and jaw surgery, often collaborating across departments and disciplines 🌐. Dr. Zhang is also a consultant in industrial biomechanics projects involving denture material strength testing and fatigue performance evaluation 🔍🧪. In addition to his administrative duties, he regularly mentors students, coordinates research labs, and publishes in high-impact journals. His dual role in academia and applied research makes him a valuable contributor to innovations in oral healthcare, implantology, and diagnostic imaging technologies 📊🧠.

Awards and Honors

Dr. Zhang’s trailblazing work in oral biomechanics has been recognized through numerous patents and academic accolades 🥇. His book Computational Biomechanics of the Musculoskeletal System is a highly cited reference in the field and showcases his authority on the subject 📘. He was awarded national patents for innovations such as MRI examination aids, implant prosthetics, and medical imaging equipment 🔬📸. These inventions reflect his problem-solving approach to real-world medical challenges. Dr. Zhang has also been honored for his role in translational research, converting complex engineering principles into practical clinical tools. While formal award citations may not be listed, his prolific publication record, interdisciplinary collaborations, and contributions to medical device development are evidence of his scholarly excellence and research leadership 💡🏅. His profile stands strong for the Best Researcher Award based on both innovation and academic impact.

Research Focus

Dr. Yuanli Zhang’s research centers on the biomechanical dynamics of the temporomandibular joint (TMJ) and the clinical implications of dental procedures such as implantation, prosthodontics, and jaw surgeries 🦷🔍. His work bridges engineering mechanics and oral medicine, offering critical insights into TMJ dysfunction caused by surgical interventions or prosthetic usage 🧠⚙️. Utilizing advanced finite element analysis (FEA) and 3D modeling software, Dr. Zhang evaluates stress distributions, joint morphology, and bite force dynamics 💻📊. His research has clinical relevance in reducing patient discomfort, improving surgical outcomes, and guiding personalized treatment planning. Ongoing projects include exploring GDF11 expression in cancer, the effect of implants on TMJ health, and the design of more adaptive oral prosthetics 🧬🧪. His interdisciplinary methodology supports innovations in diagnostic tools and therapeutic strategies, making his research both timely and transformative for the field of biomedical engineering and dental science.

Publication Top Notes

The Effect of Dental Implant Restoration on the Biomechanics of the Temporomandibular Joint in Patients with Posterior Tooth Loss: A Pilot Study

The impact of posterior tooth loss on the biomechanics of the temporomandibular joints

Morphological study of the changes after sagittal split ramus osteotomy in patients with facial asymmetry: measurements of 3-dimensional modelling

Comparison of Morphologic Parameters of Temporomandibular Joint for Asymptomatic Subjects Using the Two-Dimensional and Three-Dimensional Measuring Methods

Morphologic analysis of the temporomandibular joint between patients with facial asymmetry and asymptomatic subjects by 2D and 3D evaluation: A preliminary study

YONGFANG HU | Medicine and Health Sciences | Best Researcher Award

Posted on by Research Hypothesis

YONGFANG HU | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr YONGFANG HU, Beijing Tsinghua Changgung Hospital, China

Assoc. Prof. Dr. Yongfang Hu is a distinguished clinical pharmacist and academic with over three decades of impactful service in pharmacy and pharmacology. 📚🧬 She earned her degrees from Lanzhou University and Central South University, focusing on pharmacology and clinical pharmacology. 💊 She has held prominent roles at leading institutions such as Lanzhou University, Peking University Third Hospital, and Tsinghua Changgung Hospital. 🌟 Her pioneering research covers pharmacogenomics, organ transplant pharmacotherapy, and elderly care medication. 🧠💉 A highly respected scholar, she has authored influential publications and led studies on multidrug-resistant infections and personalized medicine. 📈🧫 Dr. Hu’s commitment to advancing safe, effective drug therapies makes her a standout candidate for the Best Researcher Award. 🌐🥇

Publication Profile

Orcid

Education

Dr. Yongfang Hu’s academic journey began with a Bachelor’s Degree in Pharmacy from the School of Pharmacy, Lanzhou University (1988). 🎓💊 She further pursued a Master’s Degree in Pharmacology from the same institution in 2000, deepening her understanding of drug mechanisms and therapeutic strategies. 🔬📘 To solidify her expertise in clinical applications, she earned a Doctorate in Clinical Pharmacology from the Institute of Clinical Pharmacology, Central South University (2005). 🧬📖 Her academic training spans fundamental pharmacy, experimental pharmacology, and patient-centered pharmacotherapy, laying a strong foundation for her research in genomics, drug therapy, and personalized medicine. 🧠🧪 Each milestone in her educational path reflects her lifelong dedication to pharmacological sciences and clinical excellence. 🏅📚

Experience

From 1988 to 2002, Dr. Hu served as a Deputy Chief Pharmacist and Associate Professor at the Second Affiliated Hospital of Lanzhou University. 🏥📘 She later joined Peking University Third Hospital (2005–2014) as a Chief Pharmacist and Associate Professor, advancing clinical pharmacy services and academic programs. 🧪📈 Between 2014 and 2015, she led the Pharmacy Department at Tsinghua Changgung Hospital, and since 2015, she continues there as a Chief Pharmacist and Associate Professor of Clinical Pharmacy. 🧬🏥 Her clinical and academic leadership across top Chinese institutions showcases her expertise in implementing advanced pharmaceutical care and mentoring future pharmacists. 💡🎓

Awards and Honors

Dr. Hu has received multiple recognitions for her excellence in pharmacy and research. 🏆 In her tenure, she has been honored with Institutional Excellence Awards for Clinical Pharmacy Innovation and Outstanding Research Contributions at Peking University Third Hospital and Tsinghua Changgung Hospital. 🎖️ She has been invited to serve on editorial boards and academic review committees, reflecting her standing in the scientific community. 📚👩‍⚕️ Her extensive work on drug genomics and personalized medicine has earned her accolades at national pharmacology conferences. 🧬🌟 These honors signify her continuous impact on both patient care and the broader medical research landscape. 🧠🏅

Research Focus

Dr. Hu’s research primarily focuses on the genomics of organ transplantation drugs and pharmacogenomics of thromboembolic diseases. 🧬🫀 She explores how genetic variations influence drug responses, aiming to tailor therapies for optimal patient outcomes. 🧠💊 She also delves into drug therapies for infectious diseases, including strategies to combat multidrug-resistant organisms, particularly in transplant patients. 🧫🛡️ Her work extends to cardiovascular pharmacotherapy and medication optimization in the elderly population, tackling polypharmacy and age-related metabolic changes. 👵❤️ Through clinical studies and predictive modeling, Dr. Hu drives personalized medicine in real-world settings. 📊🔍 Her interdisciplinary approach bridges pharmacology, genomics, and patient care. 🌐🔗

Publication Top Notes

Epidemiology and Risk Prediction Model of Multidrug-Resistant Organism Infections After Liver Transplant Recipients: A Single-Center Cohort Study 🧫🧬

Yong Ahn | Medicine and Health Sciences | Best Researcher Award

Posted on by Research Hypothesis

Yong Ahn | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Yong Ahn, Kyung Hee University Hospital, Kyung Hee University College of Medicine at Gangdong, Kyung Hee University College of Medicine, South Korea

Prof. Dr. Yong Ahn is a globally recognized leader in minimally invasive spine surgery. Having earned his MD and PhD from Seoul National University School of Medicine, Dr. Ahn has devoted his career to advancing surgical techniques that minimize patient recovery time and improve outcomes. Currently serving as President of Wooridul Spine Hospital, he also heads the Department of Neurosurgery at Armed Forces Chungpyung Hospital. Dr. Ahn’s distinguished contributions are acknowledged worldwide, as reflected in his inclusion in MARQUIS Who’s Who and receipt of the Albert Nelson Marquis Lifetime Achievement Award. He holds pivotal roles in several spine surgery societies, chairs editorial boards for prestigious journals, and actively shapes the field through extensive research and publication. His dedication and innovations make him an exemplary candidate for the Best Researcher Award.

Publication Profile

Orcid

Education

Prof. Dr. Yong Ahn completed both his MD and PhD at the prestigious Seoul National University School of Medicine in Korea. Beyond his medical degrees, he expanded his expertise internationally, becoming a Fellow of the American Board of Minimally Invasive Spinal Surgery and the Royal College of Physicians and Surgeons. His educational background is marked by a combination of rigorous academic training and a forward-looking vision for medical innovation. Dr. Ahn’s academic pursuits laid a strong foundation for his pioneering work in minimally invasive techniques and spinal endoscopy, fields in which he would later become a leading authority. His commitment to lifelong learning and professional development exemplifies the values necessary for outstanding contributions to medical science.

Experience

Dr. Yong Ahn has had an illustrious career, marked by leadership and innovation in spine surgery. He currently serves as the President of Wooridul Spine Hospital and as Head of Neurosurgery at Armed Forces Chungpyung Hospital. Dr. Ahn also plays critical roles in academic societies, including being Chairperson of the Korean Endoscopic Spine Surgery Society and Scientific Manager of the Korean Minimally Invasive Spine Surgery Society. His expertise extends to national policy, where he serves on the Inter-Ministerial Evaluation Committee for national R&D projects. As Editor-in-Chief of JMISST-Video and an editorial board member of European Spine Journal, Biomed Research International, and PLOS One, he influences scientific communication globally. His experience is distinguished by a balance between surgical excellence, academic leadership, and contributions to national and international healthcare systems.

Awards and Honors

Prof. Dr. Yong Ahn’s outstanding achievements have been recognized through numerous prestigious awards. He received the Gachon University President’s Special Award for Research Excellence in 2020, honoring his significant research contributions. In 2018, he was awarded the Albert Nelson Marquis Lifetime Achievement Award, further confirming his global impact. Dr. Ahn’s inclusion in the MARQUIS Who’s Who reflects his longstanding influence and excellence in the field of spine surgery. His leadership positions within various professional societies and editorial roles also signify peer recognition of his professional authority and contributions. Each award not only celebrates his past accomplishments but also highlights his continuing commitment to advancing medical science and patient care.

Research Focus

Dr. Yong Ahn’s research focuses primarily on minimally invasive spine surgery and endoscopic procedures. He is a pioneer in developing techniques that allow complex spinal conditions to be treated with reduced surgical trauma, faster recovery, and improved patient outcomes. His studies address critical topics such as the learning curve associated with minimally invasive techniques, surgical complications like dural tears, and innovations in endoscopic decompression procedures. Dr. Ahn’s research bridges clinical practice and technological advancement, making significant strides in the refinement of surgical methods. As an editor and author of core textbooks in his field, he also contributes to education and knowledge dissemination. His commitment to evidence-based practice ensures that his research directly benefits both the scientific community and patients worldwide.

Publication Top Notes

Magnetic Resonance Imaging Predictors of Surgical Difficulty in Transforaminal Endoscopic Lumbar Discectomy for Far-Lateral Disc Herniation Under Local Anesthesia

A Commentary on “Full-Endoscopic Resection of a Lumbar Intradural Tumor (Schwannoma): Video Case Report and Description of the Surgical Technique”

Transforaminal Endoscopic Lumbar Foraminotomy for Iatrogenic Foraminal Stenosis Following Vertebroplasty

Access Pain During Transforaminal Endoscopic Lumbar Discectomy for Foraminal or Extraforaminal Disc Herniation

Access Pain during Transforaminal Endoscopic Lumbar Discec-Tomy for Foraminal or Extraforaminal Disc Herniation

Learning Curve for Endoscopic Transsphenoidal Surgery: A Systematic Review and Meta-Analysis

Yu Pan | Medicine and Health Sciences | Young Scientist Award

Posted on by Research Hypothesis

Yu Pan | Medicine and Health Sciences | Young Scientist Award

Dr Yu Pan, Fujian Medical University Union Hospital, China

Dr. Yu Pan is a pioneering medical scientist and attending physician at the Department of General Surgery, Fujian Medical University Union Hospital, China. His groundbreaking research bridges immunotherapy and pancreatic cancer treatment, focusing on mechanisms shaping the tumor microenvironment and translating them into clinical applications. As the principal investigator of multiple prestigious grants, Dr. Pan leads a laboratory exploring mRNA vaccine development and immune regulation in pancreatic malignancies. With over a dozen high-impact publications, including in Nature Nanotechnology and JITC, his work is rapidly transforming the therapeutic landscape. An active mentor and educator, he has guided eight Master’s students, several of whom now pursue PhDs or hold clinical positions at top hospitals. Recognized for academic excellence and innovation, Dr. Pan exemplifies the qualities of a future leader in oncology and immunology. His contributions reflect a deep commitment to both science and society.

Publication Profile

Orcid

Education

Dr. Yu Pan is a dedicated medical professional with a strong academic background in Medical Sciences 🧠🔬. He began he journey in medicine at Anhui Medical University, China, where he earned he Bachelor’s degree between 2008 and 2013 🎓🇨🇳. He passion for advancing healthcare led he to pursue further studies at Fujian Medical University. From 2014 to 2017, he completed he Master’s degree in Medical Sciences, specializing in General Surgery 🏥🩺. Demonstrating exceptional commitment to surgical research and clinical excellence, Dr. Pan continued at the same university to obtain her Ph.D. in Medical Sciences from 2017 to 2020 🎓🔍. During her academic career, she gained extensive experience in surgical techniques, research methodologies, and patient care, contributing significantly to the field of general surgery 📚. He educational path reflects a continuous pursuit of knowledge and skill development, underscoring he role as a dedicated surgeon and researcher committed to medical innovation and patient well-being ❤️‍🩹.

Experience

Dr. Yu Pan is a dedicated surgical professional with extensive experience in clinical practice, teaching, and mentorship. From 2020 to 2022, Dr. Pan completed a surgical residency at the Department of Surgery, Fujian Medical University Union Hospital 🏥. Since 2022, he has served as a Staff Attending Physician in the Department of General Surgery 👨‍⚕️. Alongside his clinical duties, Dr. Pan has been actively involved in teaching as an Instructor for Clinical Skills Training Classes (2022–2024) at Fujian Medical University 🎓. He has also served as a thesis advisor for Master’s students since 2021, mentoring eight students in total. Five have graduated, with three pursuing PhDs and two now practicing at top institutions, including Jinhua Hospital and Fudan University Shanghai Cancer Center 🎯. His mentees have published in prestigious journals such as JITC, Functional Integrated Genomics, Frontiers in Pharmacology, and Cell Death & Disease 📚🔬, reflecting Dr. Pan’s strong academic impact.

Awards and Honors

Dr. Yu Pan is a highly accomplished medical researcher recognized for his consistent contributions to science and healthcare advancement 🧬🩺. He currently leads the 2025 Overseas Study Program for Young and Middle-Aged Medical Talents in Fujian Province 🌏✨. In 2023, he was selected for the Excellent Young Scholars Cultivation Project by Fujian Medical University Union Hospital (No. 2022XH025) 🧑‍🔬🏅. His expertise earned national recognition through the prestigious 2021 National Natural Science Foundation of China grant (No. 82103310) 🇨🇳🔍. That same year, he secured funding from the Natural Science Foundation of Fujian Province (No. 2021J01774) and played a pivotal role in the Joint Funds of the Scientific and Technological Innovation Program of Fujian Province (No. 2020Y9081) 💡🔬. Additionally, Dr. Pan led the 2020 Fujian Provincial Health Technology Project (No. 2020GGA029), further highlighting his dedication to medical research and innovation in the region.

Research Focus

Dr. Yu Pan’s research centers on pancreatic cancer and inflammatory-immune responses, with a strong emphasis on immune regulation, tumor microenvironment, and therapeutic targets 🧬🩸. His studies explore the role of Annexin A1, CD47-targeted therapies, and immune checkpoints in pancreatic disorders, especially pancreatic ductal adenocarcinoma (PDAC) and neuroendocrine neoplasms 🧫🧠. Through single-cell analysis, preclinical models, and clinical translation, Dr. Pan investigates how immune dynamics shape disease progression and treatment outcomes 🧪📊. His work contributes significantly to immunotherapy and precision medicine in gastrointestinal oncology, aiming to improve prognosis and treatment for patients with severe pancreatic conditions 💊🧠🧑‍⚕️.

Publication Top Notes

Annexin A1 regulates inflammatory-immune response and reduces pancreatic and extra- pancreatic injury during severe acute pancreatitis

Translating CD47-Targeted Therapy in Gastrointestinal Cancers: Insights from Preclinical to Clinical Studies

The prognostic and therapeutic value of the tumor microenvironment and immune checkpoints in pancreatic neuroendocrine neoplasms

Loss of Annexin A1 in macrophages restrains efferocytosis and remodels immune microenvironment in pancreatic cancer by activating the cGAS/STING pathway

High-dimensional single-cell analysis unveils distinct immune signatures of peripheral blood in patients with pancreatic ductal adenocarcinoma

Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreatic cancer

Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer

 

semih güler | Medicine and Health Sciences | Best Researcher Award

Posted on by Research Hypothesis

semih güler | Medicine and Health Sciences | Best Researcher Award

Mr semih güler, Sivas Numune Hospital, Turkey

Semih Güler 🎓👂 | Born in Sivas (1996), Semih Güler is a dedicated Master Audiologist passionate about advancing the science of audiology and its humanitarian impact. With top honors in his academic journey, including his Master’s from Cappadocia University, he has over five years of experience in diagnosing and treating hearing and balance disorders at Sivas Numune Hospital. Semih has contributed to academia as a lecturer at Cumhuriyet University and published impactful research on anesthesia’s effects on newborn hearing screening. A licensed football player and Turkish Art Music artist, he thrives on discipline, innovation, and mentoring future audiologists. ⚕️🎼⚽

Publication Profile

Orcid

Education and Qualifications

Semih Güler is an accomplished audiologist with a strong academic background. 🌟 He graduated as the top student 🎓 from Serik Anatolian Health Vocational High School Anesthesia and Reanimation Department (2010–2014) with a 92.12/100 score. 📚 He earned an Associate Degree in Audiometry from Ege University (2015–2016) with a stellar 3.86/4 GPA, ranking first. 🏅 Continuing his excellence, he completed a Bachelor’s in Audiology at Üsküdar University (2016–2018) with High Honors (3.62/4). 🎖️ Semih further earned a Master’s in Audiology from Kapadokya University (2019–2021), achieving a perfect 4.0/4 GPA and ranking first in his department and school. 🥇🎓

Experience

Semih Güler is a dedicated audiology professional with a rich career spanning various roles. He began as an Anesthesia Technician at Antalya Yaşam Hospital (2014), leaving to pursue his education 🎓. As an Intern Audiometrist, he trained at Ege University (2014-2016) and later served as an Intern Audiologist at Üsküdar University (2016-2018). Semih currently specializes in Hearing and Balance Disorders at Sivas Numune Hospital, where he has excelled for over five years 👂💡. He also contributed to education as a Lecturer at Cumhuriyet University (2022-2023) and supported individuals with hearing impairments at Yaşam Special Education Center (2018-2020) 📚🤝.

Professional Growth

Semih Güler’s research focus centers on advanced audiology and vestibular studies. With a strong commitment to self-improvement, he has completed numerous advanced training programs and certifications in these fields. His research explores topics such as hearing disorders, balance issues, and the impact of vestibular dysfunction on quality of life. He aims to contribute to the development of innovative diagnostic and therapeutic techniques to improve patient care and outcomes in audiology and vestibular health. 📡🧠🔍

Courses

Semih Güler has a rich background in audiology, vestibular systems, and emergency life support. 🌍🚑 His journey includes an internship in Bucharest, Romania (2013), with Romanian language training. He has completed numerous specialized trainings such as Newborn Hearing Screening 👶👂, Electrophysiology 🎛️, and Vestibular Evaluation 🎯. Semih has participated in national congresses and seminars, enhancing his expertise in audiology innovations and occupational health and safety 🩺. Notable certifications include Clinical v-HIT and f-HIT applications, wideband tympanometry, and vestibular migraine assessment 🎓. Dedicated to professional growth, Semih contributes to hearing and balance science while aligning with European and Turkish standards. ✨

Achievements

Mr. Semih Güler has excelled in his academic journey, achieving remarkable milestones 🎓🌟. He graduated first in his class from Serik Anatolian Health Vocational High School’s Anesthesia and Reanimation Department 🏅 and Ege University’s Atatürk Health Services Vocational School Audiometry Program 🥇. As a high-honor student at Üsküdar University’s Faculty of Health Sciences in Audiology 📘, he continued to shine academically. His dedication culminated in earning a Master’s Degree in Audiology with a thesis from Cappadocia University’s Graduate Education and Research Institute, where he also ranked first in his department 🥇📜. His achievements reflect his dedication and excellence! 🌟👏

Research Focus

Semih Güler’s research focuses on the effects of delivery type and anesthesia method on Auditory Brainstem Response (ABR) results in newborns. His study, published in the International Journal of Pediatric Otorhinolaryngology, investigates how different delivery methods and anesthesia impact ABR outcomes, which are crucial for newborn hearing screening. The aim is to understand how these factors influence auditory health at an early stage, contributing valuable insights for clinical practices and guidelines in neonatal care. 🌟🎧🔬

Publication Top notes

Effect of type of delivery and anesthesia method to ABR results on Newborn Hearing Screening

 

 

 

Tatsuya Nakanowatari | Medicine and Health Sciences | Best Researcher Award

Posted on by Research Hypothesis

Tatsuya Nakanowatari | Medicine and Health Sciences | Best Researcher Award

Dr Tatsuya Nakanowatari, Fukushima Medical University, Japan

Based on Dr. Tatsuya Nakanowatari’s impressive academic background and research achievements, he appears to be a strong candidate for the Best Researcher Award. Below is a summary of his accomplishments:

Publication profile

Scopus

Education and Training

Dr. Nakanowatari holds a PhD in Physiotherapy from the University of Newcastle, Australia (2023) and a Master’s degree in Disability Sciences from Tohoku University Graduate School of Medicine (2011). He also has a BS in Physical Therapy from Yamagata Prefectural University of Health Science (2004).

Research and Publications

  1. Loading Asymmetry as a Predictor of Frailty (2024) In a study published in Sensors, Dr. Nakanowatari and colleagues used in-shoe sensors to assess gait asymmetry in community-dwelling older adults. The research identified loading asymmetry as a potential predictor of frailty, a crucial finding for fall prevention and early diagnosis in aging populations.
  2. Detecting Limb Load Asymmetry (2023) In Gait Posture, Dr. Nakanowatari examined limb load asymmetry between fallers and non-fallers among older adults using in-shoe sensors. The study highlighted significant gait differences that can aid in predicting fall risk in elderly individuals, a critical area in physical rehabilitation.
  3. Plantar Force Variation during Treadmill Walking (2024) His preliminary study in Biomedical Human Kinetics explored the effects of walking speed on plantar forces across different foot regions. The research employed force-sensing insoles and provided valuable insights into the biomechanical aspects of gait.
  4. Tensor Fasciae Latae Length and Leg Length Discrepancy (2022) In a study published in the Journal of Back and Musculoskeletal Rehabilitation, Dr. Nakanowatari examined the effect of shoe lifts on the tensor fasciae latae using ultrasonic elastography. The findings contributed to understanding how artificial leg length discrepancies impact musculoskeletal health.
  5. Insular Lesion and Perception of Noxious Stimulation (2022) Published in Internal Medicine, this case study involved a patient with a unilateral insular lesion exhibiting bilaterally reduced pain perception. The research provided deeper insight into the neurological mechanisms behind pain perception and the impact of brain lesions.

Conclusion

Dr. Nakanowatari’s research primarily focuses on biomechanics, frailty, and neuromuscular health in older adults. His innovative use of sensor technology for gait analysis and muscle function assessment positions him as an influential figure in physical therapy research. His work is not only advancing scientific understanding but also making practical contributions to improving patient outcomes, making him a strong contender for the Best Researcher Award.

Publication top notes

In-Shoe Sensor Measures of Loading Asymmetry during Gait as a Predictor of Frailty Development in Community-Dwelling Older Adults

Effects of speed on plantar forces in three-foot regions during treadmill walking: A preliminary study using force sensing insoles

Detecting differences in limb load asymmetry during walking between older adult fallers and non-fallers using in-shoe sensors

The effect of a shoe lift on tensor fasciae latae length during standing with an artificial functional leg length discrepancy: An ultrasonic shear wave elastography study

A Case of Supernumerary Phantom Limb and Suspected Posterior Alien Hand Syndrome after Pontine Hemorrhage